Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence countries, India carries the highest burden of MDR-TB cases. We describe policy issues in India concerning MDR-TB diagnosis and management in a careful review of the literature including a systematic review of studies on the prevalence of MDR-TB. Of 995 articles published during 2001–2016 and retrieved from the PubMed, only 20 provided data on the population prevalence of MDR-TB. We further reviewed and describe diagnostic criteria and treatment algorithms in use and endorsed by the Revised National TB Control Program of India. We discuss problems encountered in treating MDR-TB patients with standardized regimens. Finally, we provide realistic suggestions for policymakers and program planners to improve the management and control of MDR-TB in India.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Notes and References
Mitnick, C.D. et al (2013) Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS ONE 8(3): e58664.
World Health Organization. (2015) Global Tuberculosis Control Report, (WHO/HTM/TB/2015.22) Geneva, Switzerland: World Health Organization.
Udwadia, Z.F., Pinto, L.M. and Uplekar, M.W. (2010) Tuberculosis management by private practitioners in Mumbai, India: Has anything changed in two decades? PLoS ONE 5(8): e12023.
Uplekar, M., Pathania, V. and Raviglione, M. (2001) Private practitioners and public health: Weak links in tuberculosis control. The Lancet 358(9285): 912–916.
Yadav, A. et al (2012) Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh. Indian Journal of Chest Diseases and Allied Sciences 54(3): 161–163.
Dye, C. et al (2008) Measuring tuberculosis burden, trends and the impact of control programs. The Lancet Infectious Diseases 8(4): 233–243.
Kapoor, S.K., Venkat Raman, A., Sachdeva, K.S. and Satyanarayana, S. (2012) How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS ONE 7(8): e42458.
Satyanarayana, S. et al (2011) From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS ONE 6(9): e24160.
Indian Council of Medical Research. (1959) Tuberculosis in India-A National Sample Survey: 1955–58 ICMR Special Report Series, New Delhi, No. 34.
International Institute for Population Sciences (IIPS) and Macro International. (2007) National family health survey (NFHS-3), 2005–06, Vol I. Mumbai, India: IIPS; pp. 411-418, http://www.rchiips.org/NFHS/NFHS-3%20Data/VOL-1/India_volume_I_corrected_17oct08.pdf, accessed 14 November 2014.
WHO Report. (2007) Global Tuberculosis Control. Surveillance, Planning and Financing. Geneva, Switzerland, World Health Organization WHO/HTM/TB/2007.376.
Chadha, V.K. et al (2012) Prevalence of Pulmonary Tuberculosis among Adults in a Rural Sub-District of South India. PLoS ONE 7(8): e42625.
Rao, V.G. et al (2012) Prevalence of pulmonary tuberculosis – A baseline survey in central India. PLoS ONE 7(8): e43225.
World Health Organization. (2013) Global Tuberculosis Control Report. Geneva, Switzerland: World Health Organization.(WHO/HTM/TB/2013.13).
Institute of Medicine (USA). (2012) Facing the reality of drug-resistant tuberculosis in India: Challenges and potential solutions: Summary of a joint workshop by the institute of medicine, the Indian national science academy, and the Indian council of medical research. Washington DC: National Academies Press, http://www.ncbi.nlm.nih.gov/books/NBK92617/pdf/TOC.pdf, accessed 14 November 2014.
Bhat, J. et al (2015) Situation of drug resistant tuberculosis in Saharia tribe of central India. Indian Journal of Medical Research 141(5): 636–639.
Myneedu, V. et al (2015) First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi. Journal of Epidemiology & Global Health 5: 365–373.
Selvakumar, N. et al (2015) High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. PLoS ONE 10(3): e0117421.
Salvo, F. et al (2014) Survey of tuberculosis drug resistance among Tibetan refugees in India. International Journal of Tuberculosis and Lung Disease 18(6): 655–662.
Das, D., Dwibedi, B. and Kar, S.K. (2014) Low levels of anti TB drug resistance in Rayagada district of Odisha, India. International Journal of Mycobacteriology 3(1): 76–78.
Gupta, H., Kant, S., Jain, A., Natu, S.M. and Ahluwalia, S. (2013) Initial drug resistance pattern among pulmonary tuberculosis patients. Indian Journal of Tuberculosis 60(3): 154–161.
Yadav, R., Sethi, S., Dhatwalia, S., Gupta, D., Mewara, A. and Sharma, M. (2013) Molecular characterization of drug resistance in Mycobacterium tuberculosis isolates from North India. International Journal of Tuberculosis and Lung Disease 17(2): 251–257.
Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian Journal of Medical Research 133(3): 312–315.
Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian Journal of Medical Research 133(3): 308–311.
Ramachandran, R. et al (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat. India International Journal of Tuberculosis and Lung Disease 13(9): 1154–1160.
D’Souza, D.T. et al (2009) High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Program in an urban metropolis (Mumbai) in Western India. BMC Public Health 9: 211.
Joseph, B.V. et al (2009) Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India. International Journal of Tuberculosis and Lung Disease 13(4): 494–499.
Jain, A., Mondal, R., Prasad, R., Singh, K. and Ahuja, R.C. (2008) Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian Journal of Medical Research 128(3): 300–306.
Joseph, M.R., Shoby, C.T., Amma, G.R., Chauhan, L.S. and Paramasivan, C.N. (2007) Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. International Journal of Tuberculosis and Lung Disease 11(4): 443–449.
Anuradha, B. et al (2006) Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001–2003. International Journal of Tuberculosis and Lung Disease 10(1): 58–62.
Dhingra, V.K., Rajpal, S., Bhalla, P., Yadav, A., Jain, S.K. and Hanif, M. (2003) Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Journal of Communicable Diseases 35(2): 82–89.
Negi, S.S., Gupta, S. and Lal, S. (2003) Drug resistance in tuberculosis in Delhi: A 2 year profile (2001–2002). Journal of Communicable Diseases 35(2): 74–81.
Shah, A.R., Agarwal, S.K. and Shah, K.V. (2002) Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. International Journal of Tuberculosis and Lung Disease 6(12): 1098–1101.
Paramasivan, C.N., Venkataraman, P., Chandrasekaran, V., Bhat, S. and Narayanan, P.R. (2002) Surveillance of drug resistance in tuberculosis in two districts of South India. International Journal of Tuberculosis and Lung Disease 6(6): 479–484.
Although India has 29 States and 7 Union territories as of 2014. at the time of analysis data was only available for 28 States.
Government of India Planning Commission data book. (2014) http://planningcommission.nic.in/data/datatable/0814/comp_databook.pdf, accessed 9 November 2014.
Government of India – TB India. (2014) Revised National TB Control Program Annual Status Report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20INDIA%202014.pdf, accessed 15 April 2014.
Warner, D.F. and Mizrahi, V. (2006) Tuberculosis chemotherapy: The influence of bacillary stress and damage response pathways on drug efficacy. Clinical Microbiology Review 19(3): 558–570.
WHO/IUATLD. (2004) Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Geneva, Switzerland: World Health Organization. Report No.3.
Dye, C. et al (2002) Erasing the world’s slow stain: Strategies to beat multi drug-resistant tuberculosis. Science 295(5562): 2042–2046.
Billington, O.J., McHugh, T.D. and Gillespie, S.H. (1999) Physiological cost of rifampicin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 43(8): 1866–1869.
Nardell, E. and Dharmadhikari, A. (2010) Turning off the spigot: Reducing drug-resistant tuberculosis transmission in resource-limited settings. International Journal of Tuberculosis and Lung Disease 14(10): 1233–1243.
Zhao, M. et al (2009) Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS ONE 4(2): e4370.
Grandjean, L. et al (2015) Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: A prospective cohort study. PLoS Medicine 12(6): e1001843.
Cohen, T. and Murray, M. (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Medicine 10(10): 1117–1121.
Cohen, T., Sommers, B. and Murray, M. (2003) The effect of drug resistance on the fitness of Mycobacterium tuberculosis. The Lancet Infectious Diseases 31: 13–21.
Waisbord, S. and Zimicki, S. http://www.popline.org/node/264997, accessed 9 November 2014.
Weiss, M., Auer, C., Somma, D. and Abouihia, A (2006) Gender and tuberculosis: Cross-site analysis and implications of a multi-country study in Bangladesh, India, Malawi and Colombia. Special Programme for Research and Training in Tropical Diseases (UNICEF/UNDP/World Bank/WHO), TDR/SDR/SEB/RP/06.1. Geneva, Switzerland: WHO. Report Series No. 3, http://www.who.int/tdr/publications/documents/sebrep3.pdf, accessed 5 May 2014.
Atre, S. et al (2011) Gender and community views of stigma and tuberculosis in rural Maharashtra, India. Global Public Health 6(1): 56–71.
Somma, D. et al (2008) Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia. International Journal of Tuberculosis and Lung Disease 12(7): 856–866.
Jaramillo, E. (1998) Pulmonary tuberculosis and health-seeking behaviour: how to get a delayed diagnosis in Cali, Colombia. Tropical Medicine & International Health 3(2): 138–144.
Liefooghe, R. et al (1997) From their own perspectiveA Kenyan Community’s Perception of Tuberculosis. Tropical Medicine & International Health 2(8): 809–821.
Portero, L.J. and Rubio, M. (2003) Private practitioners and tuberculosis control in the Philippines: Strangers when they meet? Tropical Medicine & International Health 8(4): 329–335.
Pinto, L.M. and Udwadia, Z.F. (2010) Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health 10: 357.
Jaggarajamma, K., Balambal, R. and Muniyandi, M. (2009) Perceptions of tuberculosis patients about private providers before and after implementation of Revised National Tuberculosis Control Program. Indian Journal of Tuberculosis 56(4): 185–190.
Uplekar, M. et al (1998) Tuberculosis patients and practitioners in private clinics in India. International Journal of Tuberculosis and Lung Disease 2(4): 324–329.
Pathania, V., Almeida, J. and Kochi, A. (1997) TB Patients and Private for Profit Health Care Providers in India. Geneva, Switzerland: World Health Organization, WHO/TB/97.223.1997.
Srivastava, D.K. et al (2011) An assessment of knowledge and practices regarding tuberculosis in the Context of RNTCP among non-allopathic practitioners in Gwalior District. Online Journal of Health and Allied Sciences 10(2): 5.
Bhargava, A., Pinto, L. and Pai, M. (2011) Mismanagement of tuberculosis in India: Causes, consequences, and the way forward. Hypothesis 9(1): e7.
Datta, K., Bhatnagar, T. and Murhekar, M. (2010) Private practitioners’ knowledge, attitude and practices about tuberculosis, Hooghly district India. Indian Journal of Tuberculosis 57(4): 199–206.
Uplekar, M., Juvekar, S. and Morankar, S. (1996) Tuberculosis patients and practitioners in private clinics, Bombay [Research Newsletter]. Foundation for Research in Community Health.
Jagota, P. (1998) Case finding policy for national tuberculosis program. Indian Journal of Tuberculosis 45(1): 3–7.
Central TB Division (CTD). (2012) Guidelines on programmatic management of drug resistant TB (PMDT) in India. Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi, http://tbcindia.gov.in/WriteReadData/l892s/8320929355Guidelines%20for%20PMDT%20in%20India%20-%20May%202012.pdf, accessed 21 February 2016.
Government of India – TB India. (2015) Revised National TB Control Program Annual Status Report, New Delhi, http://tbcindia.gov.in/showfile.php?lid=3166, accessed 25 November 2015.
Sachdeva, K. (2013) Management of tuberculosis: Indian Guidelines 2013, http://www.apiindia.org/medicine_update_2013/chap105.pdf, accessed 25 November 2015.
Census of India (State Census). (2011) http://www.census2011.co.in/states.php, accessed on 25 November 2015.
Chadha, S. et al (2011) Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLoS ONE 6(11): e26659.
Global Alliance for TB drug development. (2007) Pathway to Patients: Charting the Dynamics of the Global TB Drug Market. New York: TB Alliance.
Greaves, F., Ouyang, H., Pefole, M, MacCarthy, S. and Cash, R.A. (2007) Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India. International Journal of Tuberculosis and Lung Disease 11(1): 110–112.
Pathania, V.S. (2001) Why the Indian TB control program must stop ignoring private practitioners. International Journal of Tuberculosis and Lung Disease 5(2): 201–203.
Uplekar, M.W. and Shepard, D.S. (1991) Treatment of tuberculosis by private general practitioners in India. Tubercle 72(4): 284–290.
Gupta, S., Gupta, S. and Behera, D. (2011) Reasons for interruption of anti-tubercular treatment as reported by patients with tuberculosis admitted in a tertiary care institute. Indian Journal of Tuberculosis 58(1): 11–17.
Atre, S. (2015) Notification of multidrug-resistant tuberculosis cases and their treatment outcomes from the private sector. International Journal of Tuberculosis and Lung Disease 19(9): 1126.
Sharma, S. and Mohan, A. (2006) Multidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis control. Chest 130(1): 261–272.
Farmer, P. and Kim, J.Y. (1998) Community based approaches to the control of multidrug-resistant tuberculosis: Introducing ‘DOTS-plus’. BMJ 317(7159): 671–674.
Atre, S., D’Souza, D.T.B., Dholakia, Y.N. and Mistry, N.F. (2007) Observations on categorization of new TB cases: Implications for controlling drug resistance. International Journal of Tuberculosis and Lung Disease 11(10): 1152–1153.
Mphahlele, M. et al (2008) Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 46(10): 3459–3464.
Khurram, M., Khaar, H.T. and Fahim, M. (2012) Multidrug-resistant tuberculosis in Rawalpindi, Pakistan. The Journal of Infection in Developing Countries 6(1): 29–32.
Whitfield, M.G. et al (2015) A global perspective on pyrazinamide resistance: Systematic review and meta-analysis. PLoS ONE 10(7): e0133869.
Otu, A., Umoh, V., Habib, A., Ameh, S., Lawson, L. and Ansa, V. (2013) Drug Resistance among Pulmonary Tuberculosis Patients in Calabar. Pulmonary Medicine doi: 10.1155/2013/235190.
Franke, M. et al (2015) Counting pyrazinamide in regimens for multidrug – Resistant tuberculosis. Annals of American Thoracic Society 12(5): 674–679.
Laniado-Laborin, R. (2010) Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered. Expert Review of Respiratory Medicine 4(2): 143–146.
Suárez, P. et al (2002) Feasibility and cost – effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: A national cohort study in Peru. The Lancet 359(9322): 1980–1989.
Park, S., Lee, W.C., Lee, D.H., Mitnick, C.D., Han, L. and Seung, K.J. (2004) Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease 8(3): 361–368.
Mitnick, C. et al (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. The New England Journal of Medicine 348: 119–128.
Leimane, V. et al (2005) Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: A retrospective cohort study. The Lancet 365(9456): 318–326.
Government of India. TB India. (2013) Revised national TB control program annual status report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20India%202013.pdf, accessed 15 April 2014.
World Bank. (2013) Public health expenditure data, http://data.worldbank.org/indicator/SH.XPD.PUBL.ZS, accessed 5 March 2014.
Escombe, A.R. et al (2013) Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med 6(3): e1000043.
Sachin Atre gratefully acknowledges funding support from US Department of State through the United States India Educational Foundation (USIEF) toward his one-year Fulbright-Nehru Postdoctoral fellowship at Harvard Medical School from September 2013. The authors thank Ms. Caroline McCallum for her editorial assistance.
About this article
Cite this article
Atre, S., Murray, M. Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India. J Public Health Pol 37, 277–299 (2016). https://doi.org/10.1057/jphp.2016.14
- pathways to care